Comparison of GP5+/6+-PCR and SPF10-Line Blot Assays for Detection of High-Risk Human Papillomavirus in Samples from Women with Normal Cytology Results Who Develop Grade 3 Cervical Intraepithelial Neoplasia

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Clinical Microbiology

• Publication date

  2008-08-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/JCM.00476-08PMID 18685007PMCID PMC2566115
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs.

  2009influential reference
• Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age‐dependent

  2009influential reference
• Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

  2008cited by this paper
• Comparison of the SPF10-LiPA System to the Hybrid Capture 2 Assay for Detection of Carcinogenic Human Papillomavirus Genotypes among 5,683 Young Women in Guanacaste, Costa Rica

  2007cited by this paper
• Risk of high‐grade cervical intra‐epithelial neoplasia based on cytology and high‐risk HPV testing at baseline and at 6‐months

  2007cited by this paper
• Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial.

  2007cited by this paper
• Human papillomavirus and Papanicolaou tests to screen for cervical cancer.

  2007cited by this paper
• The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays.

  2007cited by this paper
• Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

  2007cited by this paper
• HPV testing in cervical screening.

  2006cited by this paper
• Human Papillomavirus Type–Specific 18-Month Risk of High-Grade Cervical Intraepithelial Neoplasia in Women with a Normal or Borderline/Mildly Dyskaryotic Smear

  2006cited by this paper
• Evaluation of cervical screening strategies with adjunct high‐risk human papillomavirus testing for women with borderline or mild dyskaryosis

  2006cited by this paper
• Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33‐positive women with normal cytology

  2006cited by this paper
• Overview of the European and North American studies on HPV testing in primary cervical cancer screening

  2006cited by this paper
• Cross-Sectional Comparison of an Automated Hybrid Capture 2 Assay and the Consensus GP5+/6+ PCR Method in a Population-Based Cervical Screening Program

  2006cited by this paper
• Biases in human papillomavirus genotype prevalence assessment associatedwith commonly used consensus primers

  2006cited by this paper
• Comparison of Two Commercial Assays for Detection of Human Papillomavirus (HPV) in Cervical Scrape Specimens: Validation of the Roche AMPLICOR HPV Test as a Means To Screen for HPV Genotypes Associated with a Higher Risk of Cervical Disorders

  2005cited by this paper
• Comparison of Three Different PCR Methods for Quantifying Human Papillomavirus Type 16 DNA in Cervical Scrape Specimens

  2005cited by this paper
• Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomized, controlled trial

  2005cited by this paper
• HPV‐associated flat penile lesions in men of a non‐STD hospital population: Less frequent and smaller in size than in male sexual partners of women with CIN

  2005cited by this paper
• Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA.

  2005cited by this paper
• Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

  2004cited by this paper
• Type‐specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ

  2004cited by this paper
• Epidemiologic classification of human papillomavirus types associated with cervical cancer.

  2003cited by this paper
• The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity

  2003cited by this paper
• Management of women who test positive for high-risk types of human papillomavirus: the HART study.

  2003cited by this paper
• GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes

  2002cited by this paper
• The causal relation between human papillomavirus and cervical cancer.

  2002cited by this paper
• Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance

  2002cited by this paper
• Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS).

  2002cited by this paper
• HPV testing in cervical screening

  2001cited by this paper
• PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes

  2000cited by this paper
• Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study.

  2000cited by this paper
• Technical Advance Novel Short-Fragment PCR Assay for Highly Sensitive Broad-Spectrum Detection of Anogenital Human Papillomaviruses

  1998cited by this paper
• PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems

  1997cited by this paper
• The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR.

  1995cited by this paper
• [Recommendations in aberrant findings of cytological studies of the cervix uteri].

  1987cited by this paper
• Recommendations in aberrant findings of cytological studies of the cervix uteri

  1987cited by this paper

• Evaluation of the roche MagNA pure 96 nucleic acid extraction platform for the SPF10 line probe assay system.

  2023cites this paper
• Long-Term Culture of Canine Ocular Cells That Maintain Canine Papillomaviruses

  2022cites this paper
• Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening

  2022cites this paper
• Human Papillomavirus Distribution in Women with Abnormal Pap Smear and/or Cervical Intraepithelial Neoplasia in Vaccination Era. A Single-Center Study in the North Italian Population

  2021cites this paper
• Paper-based DNA sensor enabling colorimetric assay integrated with smartphone for human papillomavirus detection

  2021cites this paper
• Simultaneous Detection and Viral DNA Load Quantification of Different Human Papillomavirus Types in Clinical Specimens by the High Analytical Droplet Digital PCR Method

  2020cites this paper
• Developing and Standardizing Human Papillomavirus Tests

  2020cites this paper
• Evidence for Missing Positive Results for Human Papilloma Virus 45 (HPV-45) and HPV-59 with the SPF10-DEIA-LiPA25 (Version 1) Platform Compared to Type-Specific Real-Time Quantitative PCR Assays and Impact on Vaccine Effectiveness Estimates

  2020cites this paper
• Identification by high-throughput sequencing of HPV variants and quasispecies that are untypeable by linear reverse blotting assay in cervical specimens

  2019cites this paper
• High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years After Vaccination in Young Dutch Women

  2018cites this paper
• Low prevalence of human papillomavirus in oral cavity squamous cell carcinoma in Queensland, Australia

  2017cites this paper
• Technical issues associated with estimating the prevalence of HPV-52 in cervical intraepithelial neoplasia

  2017cites this paper
• Comparison of urine samples and penile swabs for detection of human papillomavirus in HIV-negative Dutch men

  2016cites this paper
• Distribution of Human Papillomavirus Genotypes in Iranian Women According to the Severity of the Cervical Lesion

  2016cites this paper
• Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR

  2016cites this paper
• Establishment and characterization of a penile cancer cell line, penl1, with a deleterious TP53 mutation as a paradigm of HPV-negative penile carcinogenesis

  2016cites this paper
• Matching intended use and type of HPV test in research and clinical practice

  2015cites this paper
• The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra.

  2015cites this paper
• Presence of human papillomavirus in semen of healthy men is firmly associated with HPV infections of the penile epithelium.

  2015cites this paper
• Human papillomavirus status and p16(INK4A) expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia.

  2015cites this paper
• Improving cervical cancer screening in the HPV era

  2014cites this paper
• Cervical cancer screening: on the way to a shift from cytology to full molecular screening.

  2014cites this paper
• Evaluation of the HPV typing INNO-LiPA EXTRA assay on formalin-fixed paraffin-embedded cervical biopsy samples.

  2014cites this paper
• TEMPORARY REMOVAL: The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra.

  2014cites this paper
• New approaches for the diagnosis of human papillomavirus infection:relevance for clinical practice and cancer prevention

  2014cites this paper
• Development and Characterization of the cobas Human Papillomavirus Test

  2013cites this paper
• A Human Papilloma Virus Testing Algorithm Comprising a Combination of the L1 Broad-Spectrum SPF10 PCR Assay and a Novel E6 High-Risk Multiplex Type-Specific Genotyping PCR Assay

  2013cites this paper
• Comparison of SPF10 real-time PCR and conventional PCR in combination with the INNO-LiPA HPV Genotyping Extra assay for the detection and typing of human papillomavirus in cervical samples.

  2013cites this paper
• Near-infrared Raman Microspectroscopy Detects High-risk Human Papillomaviruses.

  2012cites this paper
• Comfort for Women Papillomavirus Detection Combined with Evalyn Brush, Providing Reliable Human Cervicovaginal Self-Sample by Use of the Dry Storage and Transport of a

  2012cites this paper
• Dry Storage and Transport of a Cervicovaginal Self-Sample by Use of the Evalyn Brush, Providing Reliable Human Papillomavirus Detection Combined with Comfort for Women

  2012cites this paper
• Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumors.

  2012cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE MEDICINA PROGRAMA DE PÓS-GRADUAÇÃO: CIÊNCIAS EM GASTROENTEROLOGIA E HEPATOLOGIA

  2012cites this paper
• Type-Specific Human Papillomavirus Infections Among Young Heterosexual Male and Female STI Clinic Attendees

  2012cites this paper
• Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes.

  2012cites this paper
• Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa

  2012cites this paper
• A review of methods for detect human Papillomavirus infection

  2012cites this paper
• Universal human papillomavirus genotyping by the digene HPV Genotyping RH and LQ Tests.

  2011cites this paper
• Human papillomavirus detection and typing using a nested-PCR-RFLP assay.

  2011cites this paper
• High-risk human papillomavirus seems not involved in DES-related and of limited importance in nonDES related clear-cell carcinoma of the cervix.

  2011influential citation
• The indicating FTA elute cartridge a solid sample carrier to detect high-risk HPV and high-grade cervical lesions.

  2011cites this paper
• Human papillomavirus detection and typing using a nested-PCR-RFLP assay

  2011cites this paper
• h-Risk Human Papillomavirus in Esophageal B & P amous Cell Carcinoma

  2010cites this paper
• Commercially available assays for multiplex detection of alpha human papillomaviruses

  2010cites this paper
• High-Risk Human Papillomavirus in Esophageal Squamous Cell Carcinoma

  2010cites this paper
• Methods for HPV detection in exfoliated cell and tissue specimens

  2010cites this paper
• Detección y tipificación del virus del papiloma humano (VPH) en mujeres con cáncer de cuello uterino en Bogotá y Barranquilla. Procedimientos técnicos y de diagnóstico

  2010cites this paper
• Population-Based Cervical Screening GP 5 + / 6 +-PCR-Enzyme Immunoassay in Detection with That of the PapilloCheck Human Papillomavirus Comparison of the Clinical Performance of

  2010cites this paper
• Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

  2009cites this paper
• Comparison of the Clinical Performance of PapilloCheck Human Papillomavirus Detection with That of the GP5+/6+-PCR-Enzyme Immunoassay in Population-Based Cervical Screening

  2009cites this paper
• Human papilloma virus in head and neck cancer: the need for a standardised assay to assess the full clinical importance.

  2009cites this paper
• High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technology.

  2009cites this paper
• Current world literature.

  2009cites this paper
• Cutaneous Human Papillomavirus in Head and Neck Squamous Cell Carcinomas

  2009influential citation
• Risk Assessment of Cervical Disease by hrHPV Testing and Cytology

  2008cites this paper
• International Quality Assurance of Human Papillomavirus Testing

  2008cites this paper